Overview of Dr. Flamiatos
Dr. Jason Flamiatos is a Urologist based in Lake Havasu City, AZ, with a comprehensive background in both clinical practice and research. He completed his residency in Urology at the University of Wisconsin Hospitals and Clinics in 2022, following his medical degree and public health studies at Oregon Health and Science University. Dr. Flamiatos has been involved with clinical trials as a coordinator and interim manager at notable institutions like Fred Hutchinson Cancer Center and OHSU Hospital. His research contributions include publications in reputable journals with several citations. He has been honored with the Rikker’s Medical Student Teaching Award and was an Alpha Omega Alpha elected member during his academic career.
Office
1851 MESQUITE AVE
STE 112
Lake Havasu City, AZ 86403
Education & Training
- University of Wisconsin Hospitals and ClinicsResidency, Urology, 2017 - 2022
- Oregon Health and Science University School of MedicineClass of 2017
- Oregon Health and Science UniversityMPH, Epidemiology and Biostatistics, 2012 - 2017
- University of PortlandBS, BA, Biology, Spanish, Cum Laude, 2003 - 2007
Certifications & Licensure
- AZ State Medical License 2022 - 2026
- WI State Medical License 2019 - 2025
- American Board of Urology Urology
Awards, Honors, & Recognition
- Rikker’s Medical Student Teaching Award University of Wisconsin, 2020
- Nominee for Resident Patient and Family Centered Care Award University of Wisconsin, 2019
- Alpha Omega Alpha (AOA) Elected Member Oregon Health & Science University, 2016
Publications & Presentations
PubMed
- 5 citationsThe end of "Cutting for Stone"? Using the lithoclast trilogy for cystolitholapaxy on a 4 cm bladder stone per urethra.Brian C. Sninsky, Jason F. Flamiatos, Stephen Y. Nakada
Urology Case Reports. 2019-07-10 - 18 citationsOpen versus robot-assisted radical cystectomy: 30-day perioperative comparison and predictors for cost-to-patient, complication, and readmissionJason F. Flamiatos, Yiyi Chen, William E. Lambert, Ann Martinez Acevedo, Thomas M. Becker
Journal of Robotic Surgery. 2019-02-01 - 23 citationsCyclooxygenase‐2 (COX‐2) inhibition for prostate cancer chemoprevention: double‐blind randomised study of pre‐prostatectomy celecoxib or placeboJason F. Flamiatos, Tomasz M. Beer, Julie N. Graff, Kristine M. Eilers, Wei Tian
BJU International. 2017-05-01
Journal Articles
- Open Versus Robot-Assisted Radical Cystectomy: 30-Day Perioperative Comparison and Predictors for Cost-to-Patient, Complication, and ReadmissionJasper C Bash, Jason F Flamiatos, William E Lambert, Christopher L Amling, Journal of Robotic Surgery
External Links
- Provider Websitehttps://www.havasuregional.com/find-a-doctor/provider/1942633805
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: